Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were found to be most protective four weeks after vaccination, providing ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

Various coronavirus vaccines have been approved, and more than 50 million people in the UK have now had at least one dose.

A fresh round of Covid-19 jabs is being rolled out in Dorset as part of the NHS' spring vaccine programme. The spring vaccination is being offered to those considered most at risk of serious illness, ...

An interim analysis published in Eurosurveillance estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...

Eligible residents are being urged to come forward for their spring Covid-19 vaccination. The vaccine is available to people aged 75 and over, resident of a care home for older adults, and people aged ...

The new study, published in JAMA Internal Medicine, found that the 2024–2025 COVID-19 vaccine continued to protect against COVID-19-associated “major adverse cardiovascular events” (MACE), which ...